Fast-track Surgery in the Treatment of Hirschsprung's Disease
NCT02350088 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2015-01-29
Summary
To evaluate the safety and efficacy of Hirschsprung's disease
Conditions
- Surgery
Interventions
- DRUG
-
probiotics
probiotics
- DRUG
-
placebo
Sponsors & Collaborators
- collaborator OTHER
-
Tongji Hospital
lead OTHER
Principal Investigators
-
Zhi Li, MD PhD · Tongji Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Year
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2015-12-31
- Completion
- 2016-01-31
Countries
- China
Study Locations
More Related Trials
-
An Open-Label Study of Oral NNZ-2591 in Pitt Hopkins Syndrome (PTHS-001)
NCT05025332 ·Status: COMPLETED ·Phase: PHASE2
-
Understanding the Role of Gut Microbiota in Hyperphagia in Prader-Willi Syndrome
NCT05541003 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Finding Trial of MK-7075 in Children and Adults With Proteus Syndrome
NCT02594215 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability Study of VTS-270 in Pediatric Participants With Niemann-Pick Type C (NPC) Disease
NCT03687476 ·Status: WITHDRAWN ·Phase: PHASE2
-
Repurposing 5-Azacytidine for the Treatment of Muscle Contractures in Children With Cerebral Palsy
NCT06377085 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Study of Sirolimus Therapy for Segmental Overgrowth Caused by Somatic PI3K Activation
NCT02428296 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study of Aldurazyme in Patients With Mucopolysaccharidosis (MPS) I
NCT00912925 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Extension of GTX-102 in Angelman Syndrome
NCT06415344 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
An Extension Study to Determine Safety and Efficacy for Pediatric Patients With MPS Type IIIA Disease Who Participated in Study HGT-SAN-093.
NCT02350816 ·Status: TERMINATED ·Phase: PHASE2
-
MK-7075 (Miransertib) in Proteus Syndrome
NCT04316546 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of ELGN-2112 on Intestinal Malabsorption in Preterm Infants
NCT05670951 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Sirolimus to Vascular Anomalies
NCT03583307 ·Status: COMPLETED ·Phase: NA
-
An Exploratory Clinical Trial of VGN-R08b in Patients With Type II Gaucher Disease
NCT06272149 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers Syndrome
NCT03781050 ·Status: UNKNOWN ·Phase: PHASE4
-
Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS
NCT02014883 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome
NCT00788073 ·Status: COMPLETED ·Phase: PHASE2
-
Mucopolysaccharidosis (MPS) I, II, and VI Screening in a High-Risk Population With Previous Surgical Repair or Presence of Inguinal and/or Umbilical Hernia in Combination With Pediatric ENT Surgery (The HATT Project)
NCT02095015 ·Status: TERMINATED
-
Study to Evaluate the Safety and EffIcacy of PRX-102 on Gastrointestinal Symptoms in Naïve Fabry Disease
NCT02921620 ·Status: WITHDRAWN ·Phase: PHASE3
-
Longitudinal Studies to Identify Biomarkers for Sturge-Weber Syndrome
NCT04717427 ·Status: RECRUITING
-
Precision Medicine for Neurocutaneous Syndromes in Western China
NCT07327164 ·Status: COMPLETED
-
Phase II Study of Glucocerebrosidase in Patients With Gaucher Disease
NCT00004293 ·Status: UNKNOWN ·Phase: PHASE2
-
Natural History Study of Serious Medical Events in PWS
NCT03718416 ·Status: COMPLETED
-
The Long-term Safety Study of Idursulfase-beta in Hunter Syndrome(Mucopolysaccharidosis II) Patients
NCT02044692 ·Status: UNKNOWN
-
Synthetic Human Secretin in Children With Autism and Gastrointestinal Dysfunction
NCT00036231 ·Status: TERMINATED ·Phase: PHASE3
-
An Open-Label Study of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001)
NCT05879614 ·Status: WITHDRAWN ·Phase: PHASE2